Effects of the introduction of new vaccines in Guinea-Bissau on vaccine coverage, vaccine timeliness, and child survival: an observational study  Dr Ane B Fisker, PhD, Linda Hornshøj, MD, Amabelia Rodrigues, PhD, Ibraima Balde, BSc, Manuel Fernandes, Prof Christine S Benn, DMSc, Prof Peter Aaby, DMSc  The Lancet Global Health  Volume 2, Issue 8, Pages e478-e487 (August 2014) DOI: 10.1016/S2214-109X(14)70274-8 Copyright © 2014 Fisker et al. Open Access article distributed under the terms of CC BY Terms and Conditions

Figure 1 Description of the 2007 and 2009 cohorts *Children living in villages where a research project provided all health interventions. The Lancet Global Health 2014 2, e478-e487DOI: (10.1016/S2214-109X(14)70274-8) Copyright © 2014 Fisker et al. Open Access article distributed under the terms of CC BY Terms and Conditions

Figure 2 Description of the 1999–2006 cohort. The Lancet Global Health 2014 2, e478-e487DOI: (10.1016/S2214-109X(14)70274-8) Copyright © 2014 Fisker et al. Open Access article distributed under the terms of CC BY Terms and Conditions

Figure 3 Mortality of children according to measles vaccination status Includes children who received measles vaccine after 12 months of age; children contributed an observation time after card inspection (at which they were classified as vaccinated or unvaccinated) and stayed in the analysis for the next 6 months. The Lancet Global Health 2014 2, e478-e487DOI: (10.1016/S2214-109X(14)70274-8) Copyright © 2014 Fisker et al. Open Access article distributed under the terms of CC BY Terms and Conditions